Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -61.9%
LRMR
Larimar Therapeutics, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 9.8 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -83.0%
- 5yr Share-Count CAGR 43.8%
Growth Quality
Weight: 15%
F
0
- Revenue-Growth Years (5) 0/5
Cash Generation
Weight: 15%
F
14
- 5yr FCF Margin 0.0%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
D-
30
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score -3.60
Stability
Weight: 15%
F
11
- Piotroski F-Score 1
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.0 of 2 gurus held; 3 full exits.
- Holders
- 0 -2
- Avg Δ position
- —
- New buys
- 0
- Full exits
- 3